...
首页> 外文期刊>Innovations in Clinical Neuroscience >Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases
【24h】

Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases

机译:与其他疾病相比,治疗精神分裂症和精神疾病的药物创新

获取原文
           

摘要

Objectives: The objectives of this study were to assess the level of private and public investment in research and development of treatments for schizophrenia and other mental disorders compared to other diseases in order to present data on the economic burden and pharmaceutical innovation by disease area, and to compare the level of investment relative to burden across different diseases.
机译:目的:本研究的目的是评估与其他疾病相比对精神分裂症和其他精神障碍治疗方法的研究和开发的私人和公共投资水平,以便按疾病领域提供有关经济负担和药物创新的数据,以及比较与不同疾病负担相关的投资水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号